Evidence map›Paper›PMID 39895033›Full record

ArticleAccounts of chemical research2025

Dibenzothiophenium Salts: Practical Alternatives to Hypervalent I(III)-Based Reagents.

Manuel Alcarazo

Abstract read
In one paragraph

Article in Accounts of chemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Thianthrenium Salts in Photochemistry.Accounts of chemical research · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Manuel AlcarazoInstitut für Organische und Biomolekulare Chemie, Georg-August-Universität Göttingen, Tammannstr 2, 37077 Göttingen, Germany.ORCID 0000-0002-5491-5682

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ConspectusDuring the past few years, the interest among organic synthesis practitioners in the use of sulfonium salts has exponentially growth. This can arguably be attributed to a series of specific factors: (a) The recent development of more direct and efficient protocols for the synthesis of these species, which make sulfonium reagents of a wide structural variety easily available in multigram scale. (b) The recognition that the reactivity of these salts resembles that of hypervalent iodine compounds, and therefore, they can be used as effective replacement of such species in most of their applications. (c) Their intrinsic thermal stability and tolerance to air and moisture, which clearly surpass that of I(III)-reagents of analogue reactivity, and facilitate their purification, isolation as well-defined species, storage, and safely handling on larger scale. (d) Finally, the possibility to further functionalize sulfonium salts once the sulfur-containing platform has been incorporated. Specifically, this last synthetic approach is not trivial when working with hypervalent I(III)-species and facilitates the access to sulfonium salts with no counterpart in the I(III) realm.This renewed interest in sulfonium salts has led to the improvement of already existing transformations as well as to the discovery of unprecedented ones; in particular, by the development of protocols that incorporate sulfonium salts as partners in traditional cross-coupling and C-H activation steps or combine them with more modern technologies such as photocatalysis or electrosynthesis. In this Account, the reactivity of a series of sulfonium salts originally prepared in our laboratory will be outlined and compared to their I(III)-counterparts. Some of these reagents are now commercially available, and their use has started to spread widely across the synthetic chemistry community, helping to speed the process of identification of potentially bioactive products or new functionaliced materials. However, challenges still remain. The development of sulfonium reagents characterized by an optimal balance between reactivity and site-selectivity, or showing broader compatibility toward sensitive functional groups is still a need. In addition, the intrinsic stability of sulfonium salts often makes necessary the use of (sophisticated) catalysts that activate the latent reactivity hidden in their structures. Although

Identifiers

PMID39895033
PMCPMC11840934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.